Developing an Automated HIV Self-Test for Use in Developing Countries
Principal investigator discusses a new research initiative to create a low-cost, rapid HIV self-test.
Diagnostic Testing and Emerging Technologies
LAB COMPLIANCE ADVISOR
LAB INDUSTRY REPORT
NATIONAL LAB REPORTER
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Principal investigator discusses a new research initiative to create a low-cost, rapid HIV self-test.
Recent study shows the new test can identify a widespread and dangerous class of synthetic cannabinoids called BZO-CHMOXIZID.
Video telehealth during the early period of the COVID-19 quarantine was actually highly effective in providing accurate diagnoses, research shows.
Recent study shows scores capable of assessing genetic risk of coronary artery disease can also ID those at high risk of death.
Though there were fewer new approvals last month, the impact of the products that did gain approval more than made up for the drop in volume.
Abbott has once more gotten the jump by becoming the first company to get EUA clearance for a commercial monkeypox RT-PCR test kit.
The rule would ensure Medicare coverage of newly approved breakthrough devices, but have stricter evidence standards.
Research offers new evidence that a test targeting blood-based biomarkers can predict someone’s risk of developing long COVID.
A recent study shows pharmacogenetic testing can help caregivers make better decisions when prescribing antidepressants.
The new CAP guidance addresses use of immune checkpoint inhibitors for evaluating and treating patients with specific cancers.
What the equity rule is, who it affects, and how to comply.